UltraSight is an Israeli medical technology company whose AI-guided Echosystem platform enables trained medical staff, not only specialist sonographers, to perform diagnostic-quality cardiac ultrasound at the point of care. Founded in 2018 and based in Rehovot, the company has received FDA clearance for its real-time AI guidance software and collaborates with Mayo Clinic on next-generation cardiac care. Its Echosystem is installed in intensive care units at more than 10 medical facilities.
1
Round
1
Industry
5
Tags
Sep 22, 2026
Latest raise
Funding activity · 1 round
Sep 22, 2026
$24M
Series C+
Led by ALIVE HealthTech Fund
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
